Navigation Links
Neurocrine Biosciences Reports First Quarter 2012 Results
Date:5/2/2012

is study assessed once-daily NBI-98854 (12.5mg or 50mg) over a two-week dosing period in 37 randomized subjects. Based on the positive outcome of this study the Company is planning to launch a large Phase IIb trial in mid-2012. This placebo controlled, double-blind, parallel design, multiple dose, twelve week study will assess six-week dosing of NBI-98854, against placebo, followed by six weeks of active treatment with NBI-98854. The study will incorporate a capsule formulation of NBI-98854.

In January of 2012, the Company was notified that the FDA Division of Psychiatry Products had granted Fast Track status to NBI-98854 for neuroleptic-induced tardive dyskinesia. The FDA's Fast Track program is designed to facilitate the development and expedite the review of drugs intended to treat serious diseases and address unmet medical needs.

Urocortin 2 Update
The Christchurch Cardioendocrine Research Group at University of Otago, Christchurch School of Medicine and Health Sciences, New Zealand, in collaboration with the Company, is conducting a Phase II study of urocortin 2 in acute decompensated heart failure patients. This study is now complete and top-line results are expected shortly.

The Company has completed several Phase I studies and two Phase II studies of urocortin 2 in patients with stable congestive heart failure. These Phase II studies showed urocortin 2 to be well tolerated with positive hemodynamic effects as evidenced by increases in cardiac output and efficiency.

Conference Call and Webcast Today at 5:00PM Eastern Time
Neurocrine will hold a live conference call and webcast today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Participants can access the live conference call by dialing 800-894-5910 (US) or 785-424-1052 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com<
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... SAN DIEGO , July 29, 2015 /PRNewswire/ ... Thursday, July 23, called the Alvarado Spine & ... orthopedic surgery and rehabilitation, focusing on spinal surgery ... method of patient care takes a patient experience-focused ... whatever clothing they feel comfortable in, rather than ...
(Date:7/29/2015)... NEW YORK , July 29, 2015   ... A. Rothenberg has joined the company as its ... role, Mr. Rothenberg will have overall responsibility for internal ... management at the company. He will report directly to ... join the company,s Senior Leadership Team. "We ...
(Date:7/29/2015)... 27, 2015 Research and Markets ( ... "Global Neurostimulation Devices Market 2015" report ... the global neurostimulation devices market to grow at ... The report, Global Neurostimulation Devices Market ... market analysis with inputs from industry experts. The ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3Global Neurostimulation Devices Market 2015-2019 2
... CITY, Calif., Aug. 9, 2011 Cardica, Inc. (Nasdaq: ... fourth quarter and year ended June 30, 2011. Cardica,s management ... today to discuss the financial results and provide an update ... 30 has now been used successfully in multiple laparoscopic procedures ...
... CAMBRIDGE, Mass., Aug. 9, 2011 Theramed Corporation, Glenveigh ... website on critical childbirth complications at http://www.jetty.ca . ... jetty™, two newly developed medical devices used in advancing ... Jetty.ca offers comprehensive resources for both patients and physicians. ...
Cached Medicine Technology:Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 2Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 3Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 4Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 5Jetty.ca Features Essential Patient and Physician Resources for Critical Childbirth Complications 2
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... as a vice president within Abt’s U.S. Health division. In her position, ... evidence-based practices. , Prior to joining Abt, Ramkeesoon spent close to a decade ...
(Date:7/29/2015)... ... 29, 2015 , ... Today the nonprofit Alliance for ... Vaccination in Older Adults, that provides a comprehensive overview of the factors that ... health care experts can improve patient compliance. , Although influenza, pneumococcal, tetanus, and ...
(Date:7/29/2015)... ... 2015 , ... Angelo’s FabriClean, an area rug cleaning company in South Surrey, ... and rugs. The company will now reverse the damage caused by water on carpets ... overhead tank, rain leaking through an accidently left open window or a broken underground ...
(Date:7/29/2015)... ... ... Ticket Down is a reliable source of authentic tickets for the international friendly ... international soccer schedule of matches played on American soil continues to grow each year. ... world’s greatest teams, Brazil, will travel to North America to compete with the United ...
(Date:7/29/2015)... Miami, FL (PRWEB) , ... July 29, 2015 , ... ... on fruit flies revealed a gene which is directly responsible for stimulating and perpetuating ... was published in the journal entitled Proceedings of the National academy of Sciences, and ...
Breaking Medicine News(10 mins):Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3
... Alan Mozes HealthDay Reporter , THURSDAY, Jan. 5 ... treat another disease might also reduce painful flare-ups in gout ... the protein-inhibitor drug rilonacept (Arcalyst) appeared to markedly lower the ... treatments aimed at lowering uric acid levels. While effective ...
... New York, NY Two non-profit organizations committed ... have joined together to address the critical shortage ... Conference Foundation, dedicated to curing pediatric cancers, has ... Research Foundation, the leading charity supporting innovative young ...
... Toddlers who miss daytime naps may be at increased risk ... Researchers looked at toddlers aged 30 months to 36 ... nap resulted in more anxiety, lower levels of joy and ... are not getting enough sleep, and for toddlers, daytime naps ...
... , WEDNESDAY, Jan. 4 (HealthDay News) -- Nearly one in ... thinks that her risk of getting other sexually transmitted diseases ... most commonly transmitted sexually transmitted infection (STI) in the United ... 14 to 19 infected. Some virus types can raise ...
... HealthDay Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Some ... of chemotherapy, and a mutation in the so-called TFAP2E gene ... Knowing which patients carry the mutation might ... the researchers said. "In our study, we identified a ...
... January 4, 2012 Abraham Kovoor was studying a brain ... the involuntary, random and repetitive body movements that are side ... While studying these side effects, which are called dyskinesia, ... College of Pharmacy, discovered that RGS9 2 also plays a ...
Cached Medicine News:Health News:Drug Eases Gout Flare-ups in Some Patients: Study 2Health News:Damon Runyon, Sohn Foundation partner to address funding shortage in pediatric cancer research 2Health News:Missed Naps Could Put Toddlers at Risk for Mood Disorders 2Health News:Many Teen Girls Mistakenly Think HPV Vaccines Cut Risk for All STDs 2Health News:Many Teen Girls Mistakenly Think HPV Vaccines Cut Risk for All STDs 3Health News:Gene Mutation Linked to Chemo-Resistant Colon Cancer 2Health News:URI pharmacy researcher discovers new gene that regulates body weight 2Health News:URI pharmacy researcher discovers new gene that regulates body weight 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: